TrialDrugs in R&D2014

Dipeptidyl peptidase-4 inhibitor (vildagliptin) improves glycemic control after meal tolerance test by suppressing glucagon release.

Aki Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.